The purpose of this study is to evaluate whether the FOCUS Family Resilience Program is effective in enhancing communication, support and quality of life among couples and families contending with cancer. The brief program is designed to build on existing strengths and provide training in specific skills and practices that have previously been shown to reduce stress and interpersonal difficulties. The study aims to determine whether participants are able to attend sessions and find value in the treatment experience. Researchers will also assess the impact of the FOCUS Program on individual stress, perceived difficulties and family resilience.

Researchers test an experimental drug or treatment in a small group of people (20-80), to evaluate its safety and identify side effects. Often these trials are not disease specific and may include more than one type of cancer.

The experimental drug or treatment is administered to a larger group of people (100-300) to determine its effectiveness and to further evaluate its safety.

The experimental drug or treatment is administered to larger groups of people (1,000-3,000) to confirm its effectiveness, monitor side effects, compare it with standard or equivalent treatment, and collect information that will allow the experimental drug or treatment to be used safely.